• Francesco Fontana, Gaetano Alfano, Giacomo Mori, Alessio Amurri, Lorenzo Tei, Marco Ballestri, Marco Leonelli, Francesca Facchini, Francesca Damiano, Riccardo Magistroni, and Gianni Cappelli.
• Struttura Complessa di Nefrologia e Dialisi, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
• Am. J. Transplant. 2020 Jul 1; 20 (7): 1902-1906.

AbstractCoronavirus disease 2019 (COVID-19) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, transplant clinicians should be readily informed about new cases of COVID-19 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome.© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

42 keywords...

hide…